[ad_1]
EU Commission President Ursula von der Leyen shared on social media after the vaccine was announced to be more than 90 percent effective against the virus.
Describing the results of the vaccine’s clinical trials as “great news,” von der Leyen said, “the EU Commission will soon sign contracts with these companies to receive up to 300 million doses of vaccine. used the expression.
Von der Leyen urged everyone to protect each other against the virus until the vaccine development phase is complete.
The EU had previously signed contracts with the pharmaceutical companies Johnson and Johnson, AstraZeneca and Sanofi-GSK to purchase vaccines, and also announced that the vaccine purchase negotiations with the companies CureVac, BioNTech-Pfizer and Moderna were successful.
The American pharmaceutical company Pfizer and the Turkish scientist Prof. Dr. The possible vaccine developed by the German biotechnology company BioNTech, of which Uğur Şahin was a founding partner, was reported to be more than 90 percent effective against the virus. It was announced that the candidate vaccine was tested in 43,538 people in 6 countries, and there have been no serious safety concerns in the trials so far.
[ad_2]
